The development of the method for the determination of terbinafine in cat's plasma and hair

Pflugers Archiv European Journal of Physiology

Volumn 440, Issue SUPPL. 5, 2000, Pages

  Erzen, N K ^a   Kuzner, J ^a   Drobnic Kossorok, M ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Cats; HPLC method; Microsporosis; Terbinafine

Indexed keywords

ANTIFUNGAL AGENT; TERBINAFINE;

ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CAT; DRUG DETERMINATION; HAIR ANALYSIS; MICROSPORUM CANIS; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ANIMAL TISSUE; ANTIFUNGAL THERAPY; ARTHRODERMA OTAE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HAIR LEVEL; DRUG ISOLATION; LIMIT OF DETECTION; LIQUID LIQUID EXTRACTION; MICROSPORUM CANIS INFECTION; RELIABILITY; REPRODUCIBILITY; ULTRAVIOLET RADIATION; VETERINARY MEDICINE;

EID: 0033826865     PISSN: 00316768     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004240000050     Document Type: Article

References (6)

1. Pharmacokinetics and pharmacology of terbinafine and itraconazole
2. Treatment of Microsporun canis infected cats with terbinafine
3. Determination of terbinafine and its desmethyl metabolite in human plasma by high-performance liquid chromatography
4. Simultaneous determination of terbinafine (Lamisil(®)) and five metabolites in human plasma and urine by high-performance liquid chromatography using on-line solid-phase extraction
5. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days
6. Analytical methods for the determination of terbinafine and its metabolites in human plasma, milk and urine